Trial Profile
Establishment of the Initial Protocol With Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization Associated With High Myopia:3 vs 1.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Mar 2023
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Myopia
- Focus Therapeutic Use
- Acronyms BENEMCOR
- 10 Mar 2023 Status changed from active, no longer recruiting to completed.
- 27 Mar 2017 Planned End Date changed from 1 Jan 2016 to 1 Dec 2017.
- 27 Mar 2017 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.